UT Southwestern, one of the premier academic medical centers in the nation, integrates pioneering biomedical research with exceptional clinical care and education. The institution’s faculty includes many distinguished members, including six who have been awarded Nobel Prizes since 1985. The faculty of more than 2,700 is responsible for groundbreaking medical advances and is committed to translating science-driven research quickly to new clinical treatments. UT Southwestern physicians provide medical care in about 80 specialties to more than 105,000 hospitalized patients, nearly 370,000 emergency room cases, and oversee approximately 3 million outpatient visits a year.
The Harold C. Simmons Comprehensive Cancer Center (SCCC) is a multidisciplinary Center responsible for the cancer care and cancer research conducted at UT Southwestern Medical Center. Simmons builds on the research strengths of UT Southwestern Medical Center and a broad network of scientific and clinical partners to develop new cancer insights and treatments. SCCC is one of just 49 NCI-designated comprehensive cancer centers in the nation, supported by the NCI P30 Comprehensive Cancer Center Support Grant, the gold standard for cancer centers across the country. In addition, SCCC is among only 30 U.S. cancer research centers to be designated by the NCI as a National Clinical Trials Network Lead Academic Participating Site.
The University of Texas Southwestern Medical Center (UT Southwestern), Department of Internal Medicine, is seeking an outstanding head and neck (H&N) medical oncologist to serve as Director of the H&N Cancer program in the Division of Hematology & Oncology. UT Southwestern Medical Center’s H&N cancer program includes a dedicated team that offers a level of expertise unmatched in Dallas and North Texas. Physicians provide patients with comprehensive, timely, and effective care in a convenient location. As the only National Cancer Institute-designated comprehensive cancer center in North Texas, UT Southwestern delivers the best cancer care available today and pushes to discover new treatments.
The primary focus of the Director role will be to direct and develop the H&N cancer clinical and research activities in the UTSW Hematology & Oncology Division. While administratively within the Department of Internal Medicine, there is a strong and important synergistic relationship to the activities of the SCCC and to basic and clinical faculty members broadly devoted to cancer pathogenesis, detection, and treatment related to H&N cancer. We expect this individual to initiate and implement plans to grow the clinical practice through teamwork with other H&N disciplines and with Divisional and SCCC partnership.
The Director of H&N Medical Oncology will collaborate with the UT Southwestern existing H&N medical oncologists, H&N surgeons, radiation oncologists and pathologists to continue to develop optimal care for all H&N patients, including those with rare or complex cancers, and to expand clinical trials, while creating distinctive educational and training opportunities for H&N clinicians.
Candidates must have a distinguished record of scholarly achievement, a strong commitment to patient care and graduate medical education, and proven leadership skills. Candidates must be board certified in medical oncology and eligible for Texas medical licensure. This position is available at the rank of Professor, Associate Professor or Assistant Professor depending on qualifications.